Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Role of the nonhelical tailpiece of myosin-II in regulating filament architecture and function.

Created on 25 Jun 2026

Authors

Kangji Wang, Shi Shu, Xiong Liu, Erfei Bi

Published in

The Journal of cell biology. Volume 225. Issue 8. Aug 03, 2026. Epub Jun 25, 2026.

Abstract

Mammalian nonmuscle myosin-II isoforms (NM-IIA, NM-IIB, and NM-IIC) each contain a nonhelical tailpiece (NHT) at their C terminus. Stop-codon mutations in the NHT of NM-IIA are linked to diseases such as macrothrombocytopenia. However, the role of the NHT in NM-II filament assembly and function remains poorly understood. Here, we show that NM-II isoforms lacking the NHT, including disease-associated NM-IIA truncations, form enlarged bipolar filaments with reduced bare zones. NHT length emerges as a key determinant of filament size. Moreover, NM-IIA NHT truncations generate stress fibers composed of enlarged bipolar filaments that exhibit reduced FRAP recovery and an increased tendency to aggregate, resulting in impaired cell migration. We further provide in vivo evidence that NM-IIA assembles into bipolar filaments in the absence of RLC phosphorylation, a property enhanced by NHT deletion. Together, these findings establish the NHT as a critical regulator of NM-II filament architecture, dynamics, and function and provide mechanistic insight into NM-IIA NHT-associated diseases.

PMID:
42347845
Bibliographic data and abstract were imported from PubMed on 25 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement